Investor Relations

Press Release

August 5, 2019

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2019

More
June 24, 2019

Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference

More
June 19, 2019

Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz

More
June 14, 2019

Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference

More
May 31, 2019

Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference

More
May 10, 2019

Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019

More
May 9, 2019

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019

More
May 6, 2019

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019

More
March 19, 2019

Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial

More
March 12, 2019

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018

More